Department of Medicine
Kimberly Trotter is a clinical rheumatologist whose primary research interest is in systemic lupus erythematosus (SLE). She is also interested in health care utilization, risk factors for developing lupus, and treatments for lupus. Her clinical interests also include rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Trotter is currently the principal investigator in an evaluation of characteristics associated with frequent emergency room usage by lupus patients. She is also the primary investigator in a randomized, multi-center clinical trial involving the use of belimumab in patients with SLE, as compared with a placebo. Additionally, she is a sub-investigator in a randomized multi-center clinical trial that is studying the effects of mycophenolate mofetil withdrawal in SLE patients with clinically inactive disease.
She earned her BS in physiology and neurobiology from the University of Maryland, College Park and her MD from the University of Maryland School of Medicine. She completed her residency in internal medicine and fellowships in rheumatology at the University of Chicago.